Characteristic |
DMPA |
NET-EN |
Monthly Injectables |
Time between injections |
3 months. |
2 months. |
1 month. |
How early or late a client can have the next injection |
2 weeks early, 4 weeks late. |
2 weeks. |
7 days. |
Injection technique |
Deep intramuscular injection into the hip, upper arm, or buttock. (Also, see Progestin-Only Injectables, New Formulation of DMPA.) |
Deep intramuscular injection into the hip, upper arm, or buttock. May be slightly more painful than DMPA. |
Deep intramuscular injection into the hip, upper arm, buttock, or outer thigh. |
Typical bleeding patterns in first year |
Irregular and prolonged bleeding at first, then no bleeding or infrequent bleeding. About 40% of users have no monthly bleeding after 1 year. |
Irregular or prolonged bleeding in first 6 months but shorter bleeding episodes than with DMPA. After 6 months bleeding patterns are similar to those with DMPA. 30% of users have no monthly bleeding after 1 year. |
Irregular, frequent, or prolonged bleeding in first 3 months. Mostly regular bleeding patterns by 1 year. About 2% of users have no monthly bleeding after 1 year. |
Average weight gain |
1–2 kg per year. |
1–2 kg per year. |
1 kg per year. |
Pregnancy rate, as commonly used |
About 3 pregnancies per 100 women in the first year. |
Assumed to be similar to DMPA. |
Average delay in time to pregnancy after stopping injections |
4 months longer than for women who used other methods. |
1 month longer than for women who used other methods. |
1 month longer than for women who used other methods. |